(Q31039719)

28 June 2017

title

Novel strategy for the selection of human recombinant Fab fragments to membrane proteins from a phage-display library (English)

1 reference

28 June 2017

0 references

5

Hanneke Schuitemaker

1 reference

28 June 2017

Aran F Labrijn

1

1 reference

28 June 2017

Marco H G M Koppelman

2

1 reference

28 June 2017

Janneke Verhagen

3

1 reference

28 June 2017

Mieke C Brouwer

4

1 reference

28 June 2017

C Erik Hack

6

1 reference

28 June 2017

Han G Huisman

7

1 reference

28 June 2017

publication date

1 March 2002

1 reference

Journal of Immunological Methods

28 June 2017

published in

1 reference

28 June 2017

volume

261

1 reference

28 June 2017

issue

1-2

1 reference

28 June 2017

page(s)

37-48

1 reference

The interaction of Sendai virus glycoprotein-bearing recombinant vesicles with cell surfaces

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Ubiquitination of the human immunodeficiency virus type 1 env glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Envelope glycoproteins of HIV-1, HIV-2, and SIV purified with Galanthus nivalis agglutinin induce strong immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Reconstitution and fusogenic properties of Sendai virus envelopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Formation of polymeric glycoprotein complexes from a flavivirus: tick-borne encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

The effects of octylglucoside on the Semliki forest virus membrane. Evidence for a spike-protein--nucleocapsid interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Enzyme immunoassay (ELISA) for the evaluation of antibodies directed to the CD4 receptor-binding site of the HIV gp120 molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Natural and designer binding sites made by phage display technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Fusion between cell membrane and liposomes containing the glycoproteins of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

In vivo selection of sFv from phage display libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Selection procedures for nonmatured phage antibodies: a quantitative comparison and optimization strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

An ELISA utilizing immobilised snowdrop lectin GNA for the detection of envelop glycoproteins of HIV and SIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Model systems to study the parameters determining the success of phage antibody selections on complex antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Pathfinder selection: in situ isolation of novel antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

HIV-1 antibody--debris or virion?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Solubilization and reconstitution of vesicular stomatitis virus envelope using octylglucoside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Methodology for selection of human antibodies to membrane proteins from a phage-display library

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Preparation and characterization of F-protein vesicles isolated from Sendai virus by means of octyl glucoside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting: applications in immunohematology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Efficient selection of scFv antibody phage by adsorption to in situ expressed antigens in tissue sections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Making antibodies by phage display technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

Human antibodies from combinatorial libraries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

7 January 2021

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

7 January 2021

Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

7 January 2021

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900542-7

7 January 2021

10.1016/S0022-1759(01)00542-7

Identifiers

DOI

1 reference

28 June 2017

1 reference